• Fund Type: Open-End Fund
  • Objective: Market Neutral
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Biotechnology Fund

+ Add to Watchlist

RYBOX:US

73.62 USD 0.59 0.80%

As of 09:29:30 ET on 08/28/2014.

Snapshot for Rydex Series - Biotechnology Fund (RYBOX)

Year To Date: +22.15% 3-Month: +17.10% 3-Year: +41.85% 52-Week Range: 53.66 - 75.12
1-Month: +10.29% 1-Year: +35.46% 5-Year: +25.42% Beta vs SPX: 1.08

Mutual Fund Chart for RYBOX

No chart data available.
  • RYBOX:US 73.62
  • 1M
  • 1Y
Interactive RYBOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYBOX

Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.

Inception Date: 09-01-2004 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / MIKE DELLAPA
Web Site: www.guggenheiminvestments.com

Fundamentals for RYBOX

NAV (on 2014-08-28) 73.62
Assets (M) (on 2014-08-28) 464.83
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYBOX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for RYBOX

Front Load 4.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.61

Top Fund Holdings for RYBOX

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 351,292 32,160,783 7.970%
Amgen Inc 205,454 26,172,785 6.486%
Biogen Idec Inc 70,401 23,541,390 5.834%
Celgene Corp 248,321 21,641,175 5.363%
Regeneron Pharmaceuticals Inc 45,519 14,394,018 3.567%
Alexion Pharmaceuticals Inc 81,686 12,987,257 3.219%
Puma Biotechnology Inc 57,086 12,657,108 3.137%
Vertex Pharmaceuticals Inc 139,857 12,434,686 3.082%
Illumina Inc 66,046 10,561,416 2.617%
Pharmacyclics Inc 71,700 8,635,548 2.140%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil